Assessment of Body Fat Distribution and Serum Liver-Type Fatty Acid-Binding Protein (L-FABP) and Neutrophil Gelatinase-Associated Lipocalin (NGAL): Potential Noninvasive Markers for Non-Alcoholic Fatty Liver Disease

(2023). Assessment of Body Fat Distribution and Serum Liver-Type Fatty Acid-Binding Protein (L-FABP) and Neutrophil Gelatinase-Associated Lipocalin (NGAL): Potential Noninvasive Markers for Non-Alcoholic Fatty Liver Disease. Egyptian Society of Diabetes and Lipidology Journal, 3(1), -. doi: 10.21608/esdlj.2023.456143

. "Assessment of Body Fat Distribution and Serum Liver-Type Fatty Acid-Binding Protein (L-FABP) and Neutrophil Gelatinase-Associated Lipocalin (NGAL): Potential Noninvasive Markers for Non-Alcoholic Fatty Liver Disease", Egyptian Society of Diabetes and Lipidology Journal, 3, 1, 2023, -. doi: 10.21608/esdlj.2023.456143

(2023). 'Assessment of Body Fat Distribution and Serum Liver-Type Fatty Acid-Binding Protein (L-FABP) and Neutrophil Gelatinase-Associated Lipocalin (NGAL): Potential Noninvasive Markers for Non-Alcoholic Fatty Liver Disease', Egyptian Society of Diabetes and Lipidology Journal, 3(1), pp. -. doi: 10.21608/esdlj.2023.456143

Assessment of Body Fat Distribution and Serum Liver-Type Fatty Acid-Binding Protein (L-FABP) and Neutrophil Gelatinase-Associated Lipocalin (NGAL): Potential Noninvasive Markers for Non-Alcoholic Fatty Liver Disease. Egyptian Society of Diabetes and Lipidology Journal, 2023; 3(1): -. doi: 10.21608/esdlj.2023.456143